Download presentation
Presentation is loading. Please wait.
Published byBartholomew Austin Modified over 9 years ago
1
The EPEC-O Curriculum is produced by the EPEC TM Project with major funding provided by NCI, with supplemental funding provided by the Lance Armstrong Foundation. Education in Palliative and End-of-life Care - Oncology The Project EPEC-O TM
2
EPECEPECOOEPECEPECOOO EPECEPECOOEPECEPECOOO Module 3b Symptoms – Anorexia / cachexia Module 3b Symptoms – Anorexia / cachexia EPEC – Oncology Education in Palliative and End-of-life Care – Oncology
3
Anorexia / cachexia... Cachexia – wasting syndrome l Lean tissue l Performance status l Altered resting energy expenditure l Appetite Cachexia – wasting syndrome l Lean tissue l Performance status l Altered resting energy expenditure l Appetite
4
... Anorexia / cachexia CachexiaStarvation Lean tissue - Fat mass Impact of feeding- + + CachexiaStarvation Lean tissue - Fat mass Impact of feeding- + +
5
Anorexia / cachexia Epidemiology l Incidence varies with site l Incidence increases with stage Epidemiology l Incidence varies with site l Incidence increases with stage
6
Anorexia / cachexia Impact ≥ 5% weight loss and poor prognosis ≥ 5% weight loss and poor prognosis l Trend toward lower chemotherapy response rates l Anorexia and poor prognosis l QOL, function l Affects caregivers Impact ≥ 5% weight loss and poor prognosis ≥ 5% weight loss and poor prognosis l Trend toward lower chemotherapy response rates l Anorexia and poor prognosis l QOL, function l Affects caregivers MacDonald N, et al. J Am Coll Surg, 2003. Dewys WD, et al. Am J Med, 1980. Loprinzi CL, et al. JCO, 1994.
7
Key points 1.Pathophysiology 2.Assessment 3.Management 1.Pathophysiology 2.Assessment 3.Management
8
Pathophysiology l Chronic inflammation l Metabolic changes l Lipolytic / proteolytic substances l Hormonal changes l Role of neurotransmitters l Cytokine impact on hypothalamus l Chronic inflammation l Metabolic changes l Lipolytic / proteolytic substances l Hormonal changes l Role of neurotransmitters l Cytokine impact on hypothalamus Todorov P, et al. Nature, 1996. Todorov P, et al. Cancer Research, 1998. Zigman JM, et al. Endocrinology, 2003. Balkwill F, et al. Lancet, 2001.
9
Assessment l Appetite / weight loss history l Identify reversible causes l Physical signs of wasting l Biochemical markers l Radiographic studies as indicated l Appetite / weight loss history l Identify reversible causes l Physical signs of wasting l Biochemical markers l Radiographic studies as indicated
10
… Assessment Reversible causes of weight loss l Psychological factors l Mucositis l Nausea / vomiting l Constipation l Early satiety l Psychological factors l Mucositis l Nausea / vomiting l Constipation l Early satiety l Malabsorption l Pain l Endocrine l Comorbid conditions l Social / economic l Malabsorption l Pain l Endocrine l Comorbid conditions l Social / economic
11
Management... l Treat comorbid conditions l Educate, support l Favorite foods / nutritional supplements / counseling l Treat reversible causes (eg, early satiety, mucositis) l Treat comorbid conditions l Educate, support l Favorite foods / nutritional supplements / counseling l Treat reversible causes (eg, early satiety, mucositis)
12
Anorexia / cachexia what does not work l Feeding (enteral or parenteral) ACP. Ann Int Med, 1989. Ovesen. J Clin Oncol, 1993.
13
Management of anorexia l Dexamethasone l Megestrol acetate l Tetrahydrocannabinol (THC) l Androgens l Dexamethasone l Megestrol acetate l Tetrahydrocannabinol (THC) l Androgens Loprinzi CL, et al. JCO, 1999. Von Roenn JH, et al. 2003. Moertel CG, et al. Cancer, 1974.
14
Management of cachexia l Investigational Anabolic steroids Omega-3-fatty acids Amino acids NSAIDsMulti-vitaminsExercise l Investigational Anabolic steroids Omega-3-fatty acids Amino acids NSAIDsMulti-vitaminsExercise Von Roenn JH, et al. ASCO, 2003. Jatoi A, et al. ASCO, 2003. Fearon KCH, et al. Gut, 2003. McMillan DC, et al. Br J Ca, 1999.
15
EPECEPECOOEPECEPECOOO EPECEPECOOEPECEPECOOO Summary Use comprehensive assessment and pathophysiology-based therapy to treat the cause and improve the cancer experience
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.